Can capmatinib be purchased in the hospital? The drug purchasing guide that patients care about is here!

Capmatinib is a targeted drug targeting MET gene mutations and is mainly used to treat advanced non-small cell lung cancer (NSCLC) . With the development of precision medicine, targeted drugs are increasingly used in cancer treatment, and capmatinib has attracted much attention due to its specific mechanism of action and clinical efficacy. MET gene mutations play an important role in certain tumor types. Especially in certain patient groups, MET amplification or abnormal activation can lead to the growth and metastasis of tumor cells. Capmatinib can effectively prevent the proliferation of tumor cells by inhibiting the MET signaling pathway, providing a new treatment option for patients with advanced NSCLC.

For patients, whether capmatinib can be purchased in the hospital is a very important issue. In China, capmatinib has been approved by the National Medical Products Administration and is available in oncology departments of some large hospitals. Patients need to be treated under the guidance of a doctor, usually through evaluation and prescription by a specialist. Therefore, whether patients can purchase capmatinib in the hospital often depends on the hospital's drug procurement situation and the doctor's advice.

Although capmatinib is available in some hospitals, access may vary between hospitals due to the higher price of the drug. In some local hospitals, patients may not be able to purchase the drug directly due to drug inventory problems or other reasons. In addition, medical insurance coverage will also affect patients' financial burden. Whether capmatinib is included in medical insurance is still a topic worthy of attention.

In conclusion, capmatinib, as an emerging targeted therapy, provides a new treatment option for patients with advanced non-small cell lung cancer. In China, it has been approved and is available for use in some hospitals, but patients need to be treated under the guidance of a doctor to ensure safety and effectiveness.

Reference materials:https://www.novartis.com/our-products/pipeline/capmatinib